Conditional neuronal nitric oxide synthase overexpression impairs myocardial contractility
Standard
Conditional neuronal nitric oxide synthase overexpression impairs myocardial contractility. / Burkard, Natalie; Rokita, Adam G; Kaufmann, Susann G; Hallhuber, Matthias; Wu, Rongxue; Hu, Kai; Hofmann, Ulrich; Bonz, Andreas; Frantz, Stefan; Cartwright, Elizabeth J; Neyses, Ludwig; Maier, Lars S; Maier, Sebastian K G; Renné, Thomas; Schuh, Kai; Ritter, Oliver.
In: CIRC RES, Vol. 100, No. 3, 16.02.2007, p. e32-44.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Conditional neuronal nitric oxide synthase overexpression impairs myocardial contractility
AU - Burkard, Natalie
AU - Rokita, Adam G
AU - Kaufmann, Susann G
AU - Hallhuber, Matthias
AU - Wu, Rongxue
AU - Hu, Kai
AU - Hofmann, Ulrich
AU - Bonz, Andreas
AU - Frantz, Stefan
AU - Cartwright, Elizabeth J
AU - Neyses, Ludwig
AU - Maier, Lars S
AU - Maier, Sebastian K G
AU - Renné, Thomas
AU - Schuh, Kai
AU - Ritter, Oliver
PY - 2007/2/16
Y1 - 2007/2/16
N2 - The role of the neuronal NO synthase (nNOS or NOS1) enzyme in the control of cardiac function still remains unclear. Results from nNOS(-/-) mice or from pharmacological inhibition of nNOS are contradictory and do not pay tribute to the fact that probably spatial confinement of the nNOS enzyme is of major importance. We hypothesize that the close proximity of nNOS and certain effector molecules like L-type Ca(2+)-channels has an impact on myocardial contractility. To test this, we generated a new transgenic mouse model allowing conditional, myocardial specific nNOS overexpression. Western blot analysis of transgenic nNOS overexpression showed a 6-fold increase in nNOS protein expression compared with noninduced littermates (n=12; P<0.01). Measuring of total NOS activity by conversion of [(3)H]-l-arginine to [(3)H]-l-citrulline showed a 30% increase in nNOS overexpressing mice (n=18; P<0.05). After a 2 week induction, nNOS overexpression mice showed reduced myocardial contractility. In vivo examinations of the nNOS overexpressing mice revealed a 17+/-3% decrease of +dp/dt(max) compared with noninduced mice (P<0.05). Likewise, ejection fraction was reduced significantly (42% versus 65%; n=15; P<0.05). Interestingly, coimmunoprecipitation experiments indicated interaction of nNOS with SR Ca(2+)ATPase and additionally with L-type Ca(2+)- channels in nNOS overexpressing animals. Accordingly, in adult isolated cardiac myocytes, I(Ca,L) density was significantly decreased in the nNOS overexpressing cells. Intracellular Ca(2+)-transients and fractional shortening in cardiomyocytes were also clearly impaired in nNOS overexpressing mice versus noninduced littermates. In conclusion, conditional myocardial specific overexpression of nNOS in a transgenic animal model reduced myocardial contractility. We suggest that nNOS might suppress the function of L-type Ca(2+)-channels and in turn reduces Ca(2+)-transients which accounts for the negative inotropic effect.
AB - The role of the neuronal NO synthase (nNOS or NOS1) enzyme in the control of cardiac function still remains unclear. Results from nNOS(-/-) mice or from pharmacological inhibition of nNOS are contradictory and do not pay tribute to the fact that probably spatial confinement of the nNOS enzyme is of major importance. We hypothesize that the close proximity of nNOS and certain effector molecules like L-type Ca(2+)-channels has an impact on myocardial contractility. To test this, we generated a new transgenic mouse model allowing conditional, myocardial specific nNOS overexpression. Western blot analysis of transgenic nNOS overexpression showed a 6-fold increase in nNOS protein expression compared with noninduced littermates (n=12; P<0.01). Measuring of total NOS activity by conversion of [(3)H]-l-arginine to [(3)H]-l-citrulline showed a 30% increase in nNOS overexpressing mice (n=18; P<0.05). After a 2 week induction, nNOS overexpression mice showed reduced myocardial contractility. In vivo examinations of the nNOS overexpressing mice revealed a 17+/-3% decrease of +dp/dt(max) compared with noninduced mice (P<0.05). Likewise, ejection fraction was reduced significantly (42% versus 65%; n=15; P<0.05). Interestingly, coimmunoprecipitation experiments indicated interaction of nNOS with SR Ca(2+)ATPase and additionally with L-type Ca(2+)- channels in nNOS overexpressing animals. Accordingly, in adult isolated cardiac myocytes, I(Ca,L) density was significantly decreased in the nNOS overexpressing cells. Intracellular Ca(2+)-transients and fractional shortening in cardiomyocytes were also clearly impaired in nNOS overexpressing mice versus noninduced littermates. In conclusion, conditional myocardial specific overexpression of nNOS in a transgenic animal model reduced myocardial contractility. We suggest that nNOS might suppress the function of L-type Ca(2+)-channels and in turn reduces Ca(2+)-transients which accounts for the negative inotropic effect.
KW - Animals
KW - Arginine
KW - Caffeine
KW - Calcium
KW - Calcium Channels, L-Type
KW - Calcium Signaling
KW - Cell Size
KW - Cells, Cultured
KW - Citrulline
KW - Cyclic GMP
KW - Doxycycline
KW - Enzyme Induction
KW - Ion Channel Gating
KW - Mice
KW - Mice, Transgenic
KW - Myocardial Contraction
KW - Myocytes, Cardiac
KW - Nitric Oxide Synthase Type I
KW - Ornithine
KW - Protein Interaction Mapping
KW - Recombinant Fusion Proteins
KW - Sarcoplasmic Reticulum Calcium-Transporting ATPases
KW - Stroke Volume
KW - Ventricular Dysfunction, Left
U2 - 10.1161/01.RES.0000259042.04576.6a
DO - 10.1161/01.RES.0000259042.04576.6a
M3 - SCORING: Journal article
C2 - 17272813
VL - 100
SP - e32-44
JO - CIRC RES
JF - CIRC RES
SN - 0009-7330
IS - 3
ER -